Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1996-05-15
1998-06-09
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 3, 514 52, 514 62, 514251, 514725, 514866, 530350, 530399, 530801, 426 72, 426 74, 426648, 426656, 426658, A61K 3800, A01N 4304, A23L 130
Patent
active
057633924
ABSTRACT:
Method for lowering the plasma glucose levels of diabetics by administering myo-inositol. Also the invention concerns a nutritional composition containing myo-inositol.
REFERENCES:
patent: 4921877 (1990-05-01), Cashmere et al.
patent: 5124360 (1992-06-01), Larner et al.
Arendup et al, Acta Neurol. Scand, vol. 80, pp. 99-102, 1989.
Greene Harry L.
Hansen Barbara C.
Ortmeyer Heidi K.
Mohamed Abdel A.
Tsang Cecilia J.
LandOfFree
Treatment of diabetes by administration of myo-inositol does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of diabetes by administration of myo-inositol, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of diabetes by administration of myo-inositol will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2199102